Susac Syndrome: Clinical characteristics, diagnostic findings and treatment in 19 cases

dc.contributor.authorKarahan, S. Zengin
dc.contributor.authorBoz, C.
dc.contributor.authorSaip, S.
dc.contributor.authorKale, N.
dc.contributor.authorDemirkaya, S.
dc.contributor.authorCelik, Y.
dc.contributor.authorDemir, S.
dc.contributor.authorKurne, A.
dc.contributor.authorTerzi, M.
dc.contributor.buuauthorOzbek, S. Erer
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri/Nöroloji Bölümü.tr_TR
dc.contributor.scopusid55325044500tr_TR
dc.date.accessioned2023-06-09T13:07:55Z
dc.date.available2023-06-09T13:07:55Z
dc.date.issued2019-08
dc.description.abstractSusac's Syndrome (SS), which was first described in 1979, is a rare and presumably autoimmune disorder characterized by encephalopathy, hearing loss, and visual disturbance resulting from branch retinal artery occlusion (BRAO). This study reports 19 SS patients' clinical characteristics, MRI features, CSF analysis, treatment strategies and outcomes. At initial presentation, only three of 19 patients demonstrated the complete clinical triad. Clinic presentation varied from isolated hemiparesis to the full triad (encephalopathy, hearing loss and visual disturbances). Corpus callosum (CC) involvement was noted in the MRI of 18 patients (97%) and BRAO was detected in 17 (95%) patients. All patients were treated with intravenous methylprednisolone after the initial assessment. This case series is presented to emphasize the differences in clinical presentation of SS and the importance of MRI and FFA in diagnosis.en_US
dc.identifier.citationKarahan, S. Z. vd. (2019). ''Susac Syndrome: Clinical characteristics, diagnostic findings and treatment in 19 cases''. Multiple sclerosis and relared disorders, 33, 94-99.en_US
dc.identifier.endpage99tr_TR
dc.identifier.issn2211-0348
dc.identifier.issn2211-0356
dc.identifier.pubmed31176296tr_TR
dc.identifier.scopus2-s2.0-85066635402tr_TR
dc.identifier.startpage94tr_TR
dc.identifier.urihttps://doi.org/10.1016/j.msard.2019.05.018
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S2211034819302226
dc.identifier.urihttp://hdl.handle.net/11452/33003
dc.identifier.volume33tr_TR
dc.identifier.wos000475740000018tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.collaborationYurt içitr_TR
dc.relation.journalMultiple sclerosis and relared disordersen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSusac syndromeen_US
dc.subjectCorpus callosumen_US
dc.subjectBranch retinal artery occlusionen_US
dc.subjectNeurosciences & neurologyen_US
dc.subject.emtreeAzathioprineen_US
dc.subject.emtreeCyclophosphamideen_US
dc.subject.emtreeImmunoglobulinen_US
dc.subject.emtreeMethylprednisoloneen_US
dc.subject.emtreeMycophenolate mofetilen_US
dc.subject.emtreeAntiinflammatory agenten_US
dc.subject.emtreeMethylprednisoloneen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeBrain diseaseen_US
dc.subject.emtreeBranch retinal artery occlusionen_US
dc.subject.emtreeCerebrospinal fluid analysisen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeClinical featureen_US
dc.subject.emtreeConvalescenceen_US
dc.subject.emtreeCorpus callosumen_US
dc.subject.emtreeDiagnostic procedureen_US
dc.subject.emtreeDrug pulse therapyen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeHearing impairmenten_US
dc.subject.emtreeHemiparesisen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeNuclear magnetic resonance imagingen_US
dc.subject.emtreeRetina fluorescein angiographyen_US
dc.subject.emtreeSusac syndromeen_US
dc.subject.emtreeTreatment outcomeen_US
dc.subject.emtreeVisual impairmenten_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeFluorescence angiographyen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreePathologyen_US
dc.subject.emtreeProceduresen_US
dc.subject.emtreeRetrospective studyen_US
dc.subject.emtreeSusac syndromeen_US
dc.subject.emtreeYoung adulten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshAnti-Inflammatory Agentsen_US
dc.subject.meshFemaleen_US
dc.subject.meshFluorescein Angiographyen_US
dc.subject.meshHumansen_US
dc.subject.meshMagnetic Resonance Imagingen_US
dc.subject.meshMaleen_US
dc.subject.meshMethylprednisoloneen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshRetrospective Studiesen_US
dc.subject.meshSusac Syndromeen_US
dc.subject.meshYoung Adulten_US
dc.subject.scopusSusac Syndrome; Fluorescence Angiography; Audiometryen_US
dc.subject.wosClinical neurologyen_US
dc.titleSusac Syndrome: Clinical characteristics, diagnostic findings and treatment in 19 casesen_US
dc.typeEditorial Material
dc.wos.quartileQ2en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: